Subramanian Balanehru, Nakeff Alexander, Media Joseph E, Wiegand Richard A, Valeriote Frederick A
Drug Discovery and Development Program, Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI 48202-3450, USA.
Anticancer Drugs. 2002 Nov;13(10):1061-8. doi: 10.1097/00001813-200211000-00010.
Cryptophycin (CP)-52, a synthetic analog of CP-1, possesses potent and selective antiproliferative activity against human solid tumors both and. Based on an algorithm developed in this laboratory using HCT-116 human colon adenocarcinoma cells, CP-52 exhibited a time- and concentration-dependent antiproliferative effect in the clonogenic assay. Inhibition of both DNA and RNA synthesis was observed in the absence of any effect on protein synthesis following a 24-h exposure to CP-52, at a time when proliferating cells were arrested in the G2/M phase of the cell cycle. In summary, we interpret these data to indicate that the selective inhibition of DNA synthesis may be a major causative factor responsible for the antiproliferative activity of CP-52 and subsequent G2/M arrest.
隐藻素(CP)-52是CP-1的合成类似物,对人类实体瘤具有强大且选择性的抗增殖活性。基于本实验室利用HCT-116人结肠腺癌细胞开发的一种算法,CP-52在克隆形成试验中表现出时间和浓度依赖性的抗增殖作用。在接触CP-52 24小时后,观察到DNA和RNA合成均受到抑制,而此时蛋白质合成未受任何影响,增殖细胞停滞在细胞周期的G2/M期。总之,我们将这些数据解释为表明DNA合成的选择性抑制可能是CP-52抗增殖活性及随后G2/M期停滞的主要致病因素。